Renaissance Technologies (RenTech)'s CGTX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 693,288 shares of Cognition Therapeutics, Inc. (CGTX) worth $797,281, representing 0.00% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in CGTX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 617,100 shares. Largest reduction occurred in Q2 2026, reducing 423,848 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Cognition Therapeutics (CGTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cognition Therapeutics (CGTX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -423,848 | Reduce 37.94% | 693,288 | $1.15 |
| Q1 2026 | +147,623 | Add 15.23% | 1.12 M | $0.76 |
| Q4 2025 | +256,013 | Add 35.88% | 969,513 | $1.35 |
| Q3 2025 | +617,100 | Add 640.15% | 713,500 | $1.35 |
| Q2 2025 | +40,700 | Add 73.07% | 96,400 | $0.31 |
| Q1 2025 | -35,400 | Reduce 38.86% | 55,700 | $0.42 |
| Q4 2024 | +2,400 | Add 2.71% | 91,100 | $0.70 |
| Q3 2024 | -1,018 | Reduce 1.13% | 88,700 | $0.47 |
| Q2 2024 | -65,982 | Reduce 42.38% | 89,718 | $1.66 |
| Q1 2024 | +143,700 | Add 1197.50% | 155,700 | $1.82 |
| Q4 2023 | +12,000 | New Buy | 12,000 | $1.83 |
| Q1 2022 | -11,764 | Sold Out | 0 | $0.00 |
| Q4 2021 | +11,764 | New Buy | 11,764 | $6.29 |
Renaissance Technologies (RenTech)'s Cognition Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Cognition Therapeutics, Inc. (CGTX) in Q4 2021, acquiring 11,764 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Cognition Therapeutics, Inc. (CGTX) for 13 quarters since Q4 2021.
Renaissance Technologies (RenTech)'s largest addition to Cognition Therapeutics, Inc. (CGTX) was in Q3 2025, adding 713,500 shares worth $963,225.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 693,288 shares of Cognition Therapeutics, Inc. (CGTX), valued at approximately $797,281.
As of the Q2 2026 filing, Cognition Therapeutics, Inc. (CGTX) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Cognition Therapeutics, Inc. (CGTX) was 1,117,136 shares, as reported at the end of Q1 2026.